STRAHLENTHERAPIE UND ONKOLOGIE

Scope & Guideline

Unveiling the future of cancer treatment and radiation therapy.

Introduction

Welcome to the STRAHLENTHERAPIE UND ONKOLOGIE information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of STRAHLENTHERAPIE UND ONKOLOGIE, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN0179-7158
PublisherSPRINGER HEIDELBERG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1986 to 2024
AbbreviationSTRAHLENTHER ONKOL / Strahlenther. Onkol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY

Aims and Scopes

The journal 'STRAHLENTHERAPIE UND ONKOLOGIE' focuses on advancing the field of radiation therapy and oncology through a diverse range of research topics. It aims to publish high-quality studies that contribute to the understanding and application of radiotherapy in various cancer types, emphasizing the integration of innovative technologies and treatment modalities.
  1. Radiotherapy Techniques and Innovations:
    The journal consistently publishes research on novel radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), and proton therapy, highlighting advancements that improve treatment precision and patient outcomes.
  2. Clinical Outcomes and Toxicity Management:
    A significant focus is placed on clinical studies that evaluate the effectiveness of various treatment regimens, including chemoradiotherapy, and their associated toxicities, with an emphasis on optimizing patient care and quality of life.
  3. Personalized and Adaptive Radiotherapy:
    Research exploring personalized treatment approaches, including the use of AI in treatment planning and adaptive radiotherapy techniques, is a core area of interest, addressing the need for tailored therapies based on individual patient characteristics.
  4. Integration of Imaging and Radiomics:
    The journal highlights the role of advanced imaging techniques, such as PET/CT and MRI, along with radiomics, in predicting treatment responses and outcomes, illustrating the growing intersection between imaging and radiotherapy.
  5. Multidisciplinary Approaches and Patient-Centered Care:
    Emphasizing the importance of a multidisciplinary approach, the journal features studies that integrate insights from various specialties, including oncology, surgery, and palliative care, to enhance patient management and treatment strategies.
The journal is witnessing a dynamic evolution in its research themes, with several emerging trends that reflect the latest advancements and priorities in the field of radiation oncology. This section outlines the currently trending research areas.
  1. Artificial Intelligence and Machine Learning:
    There is a growing trend towards the application of AI and machine learning techniques in radiation therapy, from treatment planning to predictive modeling, enhancing precision and efficiency in patient management.
  2. Immunotherapy and Radiotherapy Combinations:
    Research exploring the synergistic effects of combining immunotherapy with radiotherapy is on the rise, reflecting a shift towards integrated treatment strategies that optimize clinical outcomes for cancer patients.
  3. Patient-Centered Approaches and Quality of Life Assessments:
    Increasing attention is being paid to patient-reported outcomes and quality of life assessments in treatment protocols, emphasizing the importance of patient perspectives and experiences in oncology care.
  4. Real-World Data and Comparative Effectiveness Research:
    There is a notable trend towards utilizing real-world data to assess treatment effectiveness and safety, providing insights that complement clinical trial findings and inform clinical practice.
  5. Sustainability and Cost-Effectiveness in Oncology:
    Emerging themes around sustainability in radiation oncology practices and the evaluation of cost-effectiveness of various treatment modalities are gaining traction, reflecting broader healthcare priorities.

Declining or Waning

While the journal continues to thrive in various research areas, some themes appear to be losing prominence in recent publications. This section identifies these waning scopes, reflecting shifts in research focus within the field of radiation oncology.
  1. Traditional Radiation Techniques:
    There is a noticeable decline in studies focusing solely on conventional radiation therapy methods without the integration of advanced technologies or personalized approaches, as the field shifts towards more innovative and tailored treatment strategies.
  2. Descriptive Studies without Clinical Application:
    Research that is primarily descriptive and lacks direct clinical application or implications seems to be decreasing, as the journal increasingly favors studies that demonstrate practical outcomes and advancements in patient care.
  3. Longitudinal Studies on Historical Data:
    The emphasis on historical data analysis and retrospective studies without new insights or technological advancements appears to be waning, with a greater focus now on contemporary clinical trials and innovative methodologies.

Similar Journals

Physics & Imaging in Radiation Oncology

Bridging Physics and Oncology for Enhanced Treatment Outcomes
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Physics & Imaging in Radiation Oncology is a premier journal dedicated to advancing the interdisciplinary field of radiation oncology through innovative research and imaging technologies. Published by Elsevier, this open-access journal has made its mark since its inception in 2017, ensuring that groundbreaking findings are accessible to a broad audience. With a strong focus on the integration of physics, imaging techniques, and oncology, the journal occupies esteemed positions in the academic landscape, ranking in the top quartile for Radiation and Radiology, Nuclear Medicine and Imaging as of 2023. The journal serves as a platform for researchers, professionals, and students to share insights and foster collaboration, ultimately improving patient outcomes through enhanced imaging and treatment modalities. Based in Ireland and operating from Radarweg 29, 1043 NX Amsterdam, Netherlands, the journal aims to bridge the gap between theoretical physics and practical applications in clinical settings.

MEDICAL PHYSICS

Navigating the Future of Healthcare Through Scientific Inquiry
Publisher: WILEYISSN: 0094-2405Frequency: 12 issues/year

MEDICAL PHYSICS, published by WILEY, stands as a leading journal in the fields of biophysics, medicine, and radiology, boasting an impressive impact factor and classified within the prestigious Q1 category across multiple relevant domains. With its ISSN 0094-2405 and E-ISSN 2473-4209, the journal has been a vital resource since its inception in 1974, leading the discourse well into 2024. Hailing from the United States, MEDICAL PHYSICS serves a diverse academic audience, comprising researchers, clinicians, and students eager to engage with the latest advancements and methodologies. The journal’s authoritative presence is underscored by its Scopus rankings, placing it among the top percentile in both Medicine and Biophysics, marking it as an essential scholarly platform for innovative research and critical reviews. While not currently an Open Access journal, its commitment to curating high-quality articles ensures that readers can access groundbreaking insights into medical imaging, treatment protocols, and the theoretical underpinnings of medical physics. Explore the intersection of technology and healthcare through the esteemed pages of MEDICAL PHYSICS.

INTERNATIONAL JOURNAL OF HYPERTHERMIA

Unlocking the potential of heat in cancer therapy.
Publisher: TAYLOR & FRANCIS LTDISSN: 0265-6736Frequency: 8 issues/year

INTERNATIONAL JOURNAL OF HYPERTHERMIA, published by Taylor & Francis Ltd, is a leading peer-reviewed journal dedicated to advancing the field of hyperthermia and its applications in medical science, particularly within cancer research and related disciplines. With an ISSN of 0265-6736 and an E-ISSN of 1464-5157, this journal has been a vital resource since its establishment in 1985, offering a platform for innovative research and clinical applications aimed at improving treatment outcomes. The journal is recognized with a Q2 category ranking in several fields, including Cancer Research and Physiological Medicine, reflecting its significant contribution to scientific knowledge and clinical practices. Furthermore, it has been Open Access since 2019, ensuring that cutting-edge research is accessible to a global audience. By facilitating the exchange of ideas and fostering collaborations among researchers, professionals, and students, the INTERNATIONAL JOURNAL OF HYPERTHERMIA serves as an essential resource in the quest to exploit hyperthermia’s full potential in therapeutic settings.

Radiology and Oncology

Transforming patient outcomes with cutting-edge imaging techniques.
Publisher: SCIENDOISSN: 1318-2099Frequency: 4 issues/year

Radiology and Oncology is a prominent open access journal that has been instrumental in advancing the fields of radiology and oncology since its inception in 1992. Published by SCIENDO in Germany, this journal aims to disseminate high-quality research articles, reviews, and case studies that address critical issues in diagnostic imaging and cancer treatment. As of 2023, it holds a commendable impact factor within the Q2 category for Radiology, Nuclear Medicine, and Imaging, and a Q3 standing in the field of Oncology—reflecting its importance in these critical areas of medicine. With a focus on promoting innovative research and interdisciplinary collaboration, Radiology and Oncology is indexed in Scopus, where it ranks #122 among 333 in its category and #187 among 404 in Oncology, showcasing its wide-reaching impact and relevance. The journal is fully open access since 2007, ensuring that vital research is accessible to the global medical community and fostering advancements in patient care strategies and therapeutic methodologies. By providing a platform for the latest developments and discoveries, Radiology and Oncology is a pivotal resource for researchers, clinicians, and students dedicated to improving outcomes in cancer care through innovative imaging techniques.

Journal of Contemporary Brachytherapy

Elevating cancer treatment standards with contemporary research and practices.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1689-832XFrequency: 6 issues/year

Journal of Contemporary Brachytherapy, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished open-access journal dedicated to advancing the field of brachytherapy within the oncology and radiology domains. Since its inception in 2009, the journal has provided a platform for researchers, clinicians, and students to share innovative findings, cutting-edge techniques, and clinical experiences, contributing significantly to evidence-based practices in cancer treatment. With an ISSN of 1689-832X and E-ISSN 2081-2841, the journal has established its presence globally, and it is indexed in Scopus, achieving a commendable standing among its peers—with rankings of #196 in Radiology, Nuclear Medicine, and Imaging and #260 in Oncology for 2023. Notably, it holds a Q3 quartile classification, reflecting its emerging influence in these critical fields. The journal is committed to open science, ensuring that research is accessible to a wide audience, which is particularly vital for the ongoing development of methodologies and the implementation of best practices in brachytherapy. Exploring topics from the technical aspects of brachytherapy procedures to patient management strategies, the Journal of Contemporary Brachytherapy is an essential resource for those looking to stay at the forefront of oncological advancements.

Journal of Medical Imaging and Radiation Oncology

Exploring New Horizons in Medical Imaging and Radiation Therapy
Publisher: WILEYISSN: 1754-9477Frequency: 8 issues/year

Journal of Medical Imaging and Radiation Oncology, published by WILEY, is a pivotal resource in the fields of oncology and medical imaging. With an impact factor reflective of its commitment to advancing research, the journal has maintained a robust reputation since its inception in 2008 and continues to thrive through 2024. It is indexed with an insightful ranking, with a Q2 classification in Radiology, Nuclear Medicine and Imaging, affirming its importance in these disciplines. This journal not only serves as an open access platform, allowing extensive reach and accessibility, but also fosters a scholarly community dedicated to the innovation of imaging techniques and radiation oncology practices. As a key player in disseminating crucial findings and advancements, it appeals to researchers, clinicians, and students who aim to contribute to the evolving landscape of medical imaging and cancer treatment methodologies. The journal is based in Australia, at 111 River St, Hoboken, NJ, and invites submissions that push the boundaries of current knowledge in this critical area of healthcare.

RADIATION RESEARCH

Bridging fundamental insights with applied radiation research.
Publisher: RADIATION RESEARCH SOCISSN: 0033-7587Frequency: 12 issues/year

RADIATION RESEARCH is a prestigious journal published by the RADIATION RESEARCH SOC that serves as a vital resource for professionals and researchers in the fields of biophysics, radiation science, and radiology. Established in 1954, this journal has consistently advanced the study of radiation's effects on health and the environment, bridging fundamental and applied research. It boasts an impressive impact factor reflected in its quartile rankings, including Q2 in Biophysics and Q1 in Radiation, making it a highly regarded publication within its discipline. Researchers will find valuable insights through rigorous peer-reviewed articles that explore innovative methodologies and findings related to radiation exposure, imaging technologies, and the biological consequences of radiation. Although the journal does not currently offer open access, it remains a vital reference for academia and industry, fostering a deeper understanding of radiation sciences and their implications for future research and public health.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Elevating Cancer Research to New Heights
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0277-3732Frequency: 12 issues/year

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of oncology and cancer research, focusing on the latest advancements in clinical trials and therapeutic strategies for cancer management. With an ISSN of 0277-3732 and an E-ISSN of 1537-453X, this journal serves as an essential resource for the dissemination of high-quality research findings, scholarly reviews, and innovative methodologies, aiming to advance clinical oncology from 1982 to 2024. It is categorized in Q3 for Cancer Research and Q2 for Oncology, reflecting its significant role in the scientific community. In addition to its rigorous peer-reviewed content, the journal provides a platform for researchers and clinicians to share valuable insights, laying the groundwork for future breakthroughs in cancer treatment. Although it currently does not offer open-access options, the journal remains accessible to a wide audience through academic institutions and libraries. The AMERICAN JOURNAL OF CLINICAL ONCOLOGY is crucial for anyone involved in oncology research, making it a must-read for professionals dedicated to improving cancer care.

Journal of Radiosurgery and SBRT

Bridging Science and Practice in SBRT
Publisher: OLD CITY PUBLISHING INCISSN: 2156-4639Frequency: 4 issues/year

Journal of Radiosurgery and SBRT is a dedicated platform for advancing the field of radiosurgery and stereotactic body radiation therapy (SBRT), published by OLD CITY PUBLISHING INC. With its ISSN 2156-4639 and E-ISSN 2156-4647, this journal serves researchers and practitioners keen on the latest findings and methodologies in the domains of radiological technology and surgical oncology. Operating from Spain, the journal has established itself within notable quartiles, ranking Q3 in 2023 across categories including Radiological and Ultrasound Technology, Radiology, Nuclear Medicine and Imaging, and Surgery. The journal is indexed in Scopus, with rankings that place it at #311 in Medicine Surgery and #232 in Medicine Radiology categories, reflecting its significance in the academic community. Although it does not currently offer an open-access model, the Journal of Radiosurgery and SBRT aims to foster innovation and collaboration, making it an essential resource for those involved in cutting-edge research and clinical practice in radiosurgery.

SEMINARS IN RADIATION ONCOLOGY

Empowering Cancer Treatment through Innovative Research
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1053-4296Frequency: 4 issues/year

SEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.